ViaLase is thrilled to be joining the premier thought leaders in the interventional glaucoma space at the upcoming Interventional Glaucoma Consortium (IGC)! We can’t wait to advance the conversation around emerging technologies and contribute to meaningful discussions that push the boundaries of what’s possible for patient care. To learn more about ViaLase at IGC and our cutting-edge, incision-free glaucoma treatment, visit vialase.com.
关于我们
ViaLase, Inc. is an ophthalmic med-tech, venture capital backed company located in Aliso Viejo, CA. ViaLase is focused on disrupting the conventional glaucoma treatment paradigm with the introduction of a truly noninvasive image-guided femtosecond laser treatment to enhance glaucoma patient care. The ViaLase team has vast experience developing, designing, manufacturing, and commercializing the first femtosecond lasers for Ophthalmic surgery for the refractive patient and cataract patient; and now bringing that expertise to the glaucoma patient. ViaLase? products are currently not for sale, pending regulatory clearance.
- 所属行业
- 医疗设备制造业
- 规模
- 11-50 人
- 总部
- Aliso Viejo,CA
- 类型
- 私人持股
地点
-
主要
95 Enterprise
Suite 100
US,CA,Aliso Viejo,92656
ViaLase, Inc员工
动态
-
A new era of incision-free glaucoma therapy is fast approaching... In a recent EyeWorld Magazine?editorial, Dr. Richard Lewis MD and Dr. Inder Singh explore groundbreaking laser technologies and procedures for treating glaucoma—spotlighting?ViaLase's?pioneering, incision-free femtosecond laser procedure called FLIGHT (Femtosecond laser image-guided high-precision trabeculotomy). Read the full piece here:?https://bit.ly/4dQgrI7
-
?? VIALASE IS READY TO SOAR AT AAO 2024 IN CHICAGO! Join us at?Eyecelerator?as we unveil new details on our pioneering, incision-free FLIGHT procedure with our game-changing, femtosecond laser technology. Don’t miss the opportunity to hear from our very own Chief Medical Officer, Richard Lewis MD, as he shares how ViaLase is shaping the future of glaucoma care. Learn more at?vialase.com?and?register for?Eyecelerator?@ AAO 2024 at?https://bit.ly/4eCUKfP.
-
The current glaucoma treatment landscape is ripe for disruption... In a recent Ocular Surgery News article, John Hovanesian, MD, FACS, explains why he believes?ViaLase's?pioneering technology can potentially address a major unmet need in glaucoma. Thanks to Healio | Ocular Surgery News for the feature! Read the full article here:?https://bit.ly/3WN2AMa
-
Yes, it's real... ViaLase is revealing a new era of incision-free glaucoma treatment. Our pioneering femtosecond laser-based technology will soon bring a new level of imaging and precision to glaucoma care. See for yourself at seeingisbelieving.us
-
We had an action-packed few days in Barcelona, where we showcased ViaLase’s pioneering femtosecond laser technology throughout the show. A heartfelt thank you to our esteemed advisory board members, including Professor H. Burkhard Dick and Professor Zoltan Nagy, for their outstanding presentations. Couldn't join us at ESCRS? Discover more about our cutting-edge, incision-free glaucoma treatment at seeingisbelieving.us!
Learn more about our cutting-edge, incision-free glaucoma treatment!
-
Rick Lewis, MD, Chief Medical Officer of ViaLase, proudly took to the stage at the The European Society of Cataract and Refractive Surgeons (ESCRS) iNovation Day to share his perspective on our pioneering technology that’s set to change the glaucoma game. Read the @CAKE Magazine spotlight article here: https://lnkd.in/gqqG7ATt
-
?? What a way to kick off ESCRS! ?? Thank you, Sheraz Daya, as well as the rest of our distinguished advisory board for your invaluable support in paving the way for our European commercial launch! Ike Ahmed Gus Gazzard Karsten Klabe Elena Arrondo Ticiana De Francesco Robert Ang Paz Orts Zoltan Z Nagy Burkhard Dick #ophthalmology #medtech #glaucoma
What a bunch of powerful ophthalmologists- feel like an #imposter ! ViaLase, Inc The future is “FLIGHT” watch this space !
-
ViaLase is ready to take?FLigHT?at the upcoming 2024 ESCRS Congress! Join?ViaLase's?Chief Commercial?Officer, Shawn O'Neil, at?Ophthalmology Futures European Forum?on September 5?immediately before ESCRS. On September 6, head to ESCRS?iNovation?Day to hear from?ViaLase's?Chief Medical Officer, Rick Lewis, MD. And don’t miss H. Burkhard Dick, MD, PhD, speak on September 7 at?Teleon 's?booth. Later that evening, be sure to check out Professor Zoltan Nagy's E-Poster Presentation. At these upcoming?sessions, we'll be discussing how?ViaLase's?pioneering femtosecond laser technology will shape the future of ophthalmology in Europe and beyond. For full event details, see the registration links below. Register for Ophthalmology Futures:?https://bit.ly/3T9vbKy Register for ESCRS:?https://bit.ly/4cJU0Uj
-
Did you miss our symposium at this year's European Glaucoma Society congress? In the most recent issue of Cataract & Refractive Surgery Today Global, thought leaders?Elena Arrondo, MD, Marta Ibarz Barberá, MD, PhD, Karsten Klabe, MD, and Andrew Tatham, MD?share how?ViaLase’s femtosecond laser image-guided, high-precision trabeculotomy (FLIGHT) is fueling the practice of noninvasive interventional glaucoma. Read the article here:?https://bit.ly/4cty93m